These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35379641)

  • 21. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancing the public health impact of latent tuberculosis infection diagnosis and treatment (ACT4): protocol for a cluster randomised trial.
    Oxlade O; Trajman A; Benedetti A; Adjobimey M; Cook VJ; Fisher D; Fox GJ; Fregonese F; Hadisoemarto P; Hill PC; Johnston J; Long R; Obeng J; Ruslami R; Valiquette C; Menzies D
    BMJ Open; 2019 Mar; 9(3):e025831. PubMed ID: 30898826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.
    Zenner D; Loutet MG; Harris R; Wilson S; Ormerod LP
    Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
    Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
    Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.
    Berrocal-Almanza LC; Botticello J; Piotrowski H; Karnani N; Kon OM; Lalvani A; Zenner D
    Int J Tuberc Lung Dis; 2019 May; 23(5):563-570. PubMed ID: 31097064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent tuberculosis infection screening and treatment in congregate settings (TB FREE COREA): protocol for a prospective observational study in Korea.
    Min J; Kim HW; Stagg HR; Lipman M; Rangaka MX; Myong JP; Yim HW; Lim JU; Lee Y; Koo HK; Lee SS; Park JS; Cho KS; Kim JS
    BMJ Open; 2020 Feb; 10(2):e034098. PubMed ID: 32075836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Provision and uptake of routine antenatal services: a qualitative evidence synthesis.
    Downe S; Finlayson K; Tunçalp Ö; Gülmezoglu AM
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012392. PubMed ID: 31194903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis.
    Campbell JR; Johnston JC; Ronald LA; Sadatsafavi M; Balshaw RF; Cook VJ; Levin A; Marra F
    Am J Kidney Dis; 2019 Jan; 73(1):39-50. PubMed ID: 30269868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    Shamputa IC; Nguyen DTK; Higazy D; Abdelhadi A; MacKenzie H; Reddin M; Barker K; Webster D
    PLoS One; 2022; 17(11):e0277255. PubMed ID: 36331954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of tuberculosis in migrant children in Switzerland and relevance of current screening guidelines.
    Boukamel M; Fougère Y; Gehri M; Suris JC; Rochat I; Miletto D; Kyrilli S; Fouriki A; Crisinel PA
    Swiss Med Wkly; 2020 Jun; 150():w20253. PubMed ID: 32557426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent Tuberculosis in Pregnancy: A Systematic Review.
    Malhamé I; Cormier M; Sugarman J; Schwartzman K
    PLoS One; 2016; 11(5):e0154825. PubMed ID: 27149116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling the Cost-Effectiveness of Latent Tuberculosis Screening and Treatment Strategies in Recent Migrants to a Low-Incidence Setting.
    Dale KD; Abayawardana MJ; McBryde ES; Trauer JM; Carvalho N
    Am J Epidemiol; 2022 Jan; 191(2):255-270. PubMed ID: 34017976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between social risk factors and latent tuberculosis infection among individuals residing in England: a cross-sectional study.
    Lule SA; Gupta RK; Krutikov M; Jackson C; Southern J; Abubakar I
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33293291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for latent TB, HIV, and hepatitis B/C in new migrants in a high prevalence area of London, UK: a cross-sectional study.
    Hargreaves S; Seedat F; Car J; Escombe R; Hasan S; Eliahoo J; Friedland JS
    BMC Infect Dis; 2014 Dec; 14():657. PubMed ID: 25466442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Prevalence of Active Tuberculosis among High-Risk Pregnant and Postpartum Women in Sweden: A Retrospective Epidemiological Cohort Study Using and Evaluating TST as Screening Method.
    Bullarbo M; Barnisin M; Vukas Radulovic N; Mellgren Å
    Infect Dis Obstet Gynecol; 2018; 2018():3153250. PubMed ID: 30154639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Usemann J; Ledergerber M; Fink G; Ritz N
    Int J Tuberc Lung Dis; 2019 May; 23(5):579-586. PubMed ID: 31097066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data.
    Kawatsu L; Uchimura K; Ohkado A
    BMC Infect Dis; 2021 Jan; 21(1):42. PubMed ID: 33422003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.
    Rustage K; Lobe J; Hayward SE; Kristensen KL; Margineanu I; Stienstra Y; Goletti D; Zenner D; Noori T; Pareek M; Greenaway C; Friedland JS; Nellums LB; Hargreaves S;
    Lancet Infect Dis; 2021 Dec; 21(12):1701-1712. PubMed ID: 34363771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.